OUR COMPANY

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

The technology perfected by X’prochem is used for the chemical synthesis of proteins ranging from 50-400 amino acids.

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

Our approach allows to overcome common shortcomings of the recombinant method: insufficient production, inadequate purification or randomly located modifications

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

The technology also offers an attractive alternative for producing generic biologics.

OUR TECHNOLOGY

Our technology is extremely efficient, versatile and scalable under GMP conditions.

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

A large variety of proteins can be produced

As single entities

With precisely located substitutions or side-chains

And the correct folding

Multiple properly paired disulfide bridges can readily be engineered.

Opening new avenues

New generations of biologic medicines can now be designed and manufactured under GMP conditions.

A large variety of specific, precisely controlled modifications can be reliably engineered.

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

PEGylation, phosphorylation, glycosylation, acylation etc.

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

Unnatural amino acids

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

Fusion proteins

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

Cyclic protein

OUR OFFER

We aim to become a major partner in the development of new biologics and bio-generics.

 

Our fully synthetic approach can solve intractable challenges of the recombinant methods.

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

Capabilities

Synthesis and purification of proteins not feasible by recombinant methods

Excellent yields

De novo synthesis of unnatural sequences

Custom-modifications for lead optimization

Precisely located side-chains

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

Our process

Confidential sequence disclosure

Proof of concept 1-10 mg in 4-10 weeks

Process optimization

Validation and scale-up

1-100g under GMP

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

Quality standards

Certificate of analysis (identity, purity …)

Biologic activity

Ad hoc release tests as needed

The management team combines scientific and business expertise

Reda Mhidia, PhD

President, co-founder

Developer of the proprietary ligation technology

Julien Dheur, PhD

Director and Head of R&D, co-founder

Developer of the proprietary ligation technology

Denis Henrard

COO

>20 years of global business management and development experience (J&J, Abbott Laboratories US…)

Philippe Grit

Head of Sales

>20 years of successful commercial experience in the pharmaceutical industry

For a confidential protein synthesis evaluation, please contact us

Address

1, rue du Professeur Calmette
59021 Lille Cedex - FRANCE

Email

contact@xprochem.fr

Phone

+33 641 97 71 59
Top